Vital Farms Inc vs 22nd Century Group Inc — how do they compare? Vital Farms Inc trades at $9.37 (market cap $405.27M), while 22nd Century Group Inc trades at $0.8 (market cap $621.67K). The key difference: Vital Farms Inc is far larger — about 651.9× 22nd Century Group Inc's market cap, and 22nd Century Group Inc is more actively traded (45,625 versus 1,810,837). Which is the better fit depends on your goals — on Pluang, investors hold Vital Farms Inc for 14 Days and 22nd Century Group Inc for 32 Days on average.
| VITL | XXII | |
|---|---|---|
Market Cap | $405.27M | $621.67K |
Volume | 1,810,837 | 45,625 |
Sector | Consumer Staples | Consumer Staples |
52-Week High | $43.68 | $483.00 |
52-Week Low | $8.28 | $0.80 |
Typical Hold Time | 14 Days | 32 Days |
Enterprise Value | $492.28M | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
Vital Farms (VITL) trades at $9.33, showing modest daily gains but facing significant fundamental challenges. The company reported declining revenue and profitability in 2026, with net income margin collapsing to 0.02% from 8.72% in 2025. Technical indicators show bearish momentum, while analyst sentiment remains cautiously optimistic with a $13.11 consensus target. Recent news highlights strategic review possibilities and institutional accumulation despite operational headwinds.
The outlook remains challenging with pricing pressure and supply issues affecting margins, though strategic options exploration provides potential upside. Investment opportunity exists if operational improvements materialize, but risks include sustained margin compression and execution challenges in a competitive egg market.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →